IMP
Process View
myeloid cell activation involved in immune response
A change in the morphology or behavior of a myeloid cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "myeloid cell activation involved in immune response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SYK | spleen tyrosine kinase | 0.485 | Mouse Rat | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.435 | ||
| BLNK | B-cell linker | 0.369 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.209 | ||
| NRP1 | neuropilin 1 | 0.180 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.165 | ||
| EGFR | epidermal growth factor receptor | 0.153 | ||
| LAT | linker for activation of T cells | 0.123 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.117 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.110 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.103 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.100 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.089 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.084 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.083 | ||
| SLA | Src-like-adaptor | 0.081 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.074 | Mouse | |
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.066 | ||
| IL4R | interleukin 4 receptor | 0.061 | Mouse | |
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.056 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.056 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.055 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.055 | ||
| C19orf50 | chromosome 19 open reading frame 50 | 0.044 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.042 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.040 | ||
| HCK | hemopoietic cell kinase | 0.038 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.037 | Mouse | |
| CAV2 | caveolin 2 | 0.036 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.035 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.034 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.031 | ||
| TFF1 | trefoil factor 1 | 0.027 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.025 | Human | |
| ANXA2 | annexin A2 | 0.024 | ||
| FYB | FYN binding protein | 0.022 | ||
| CRH | corticotropin releasing hormone | 0.021 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.021 | Human | |
| PPL | periplakin | 0.021 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.021 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.020 | ||
| IDE | insulin-degrading enzyme | 0.020 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.019 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.019 | Human | |
| ANKRD27 | ankyrin repeat domain 27 (VPS9 domain) | 0.019 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.019 | ||
| IL4 | interleukin 4 | 0.019 | Mouse | |
| NLRC4 | NLR family, CARD domain containing 4 | 0.018 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.018 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.018 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.018 | ||
| TNF | tumor necrosis factor | 0.017 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.017 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.017 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 0.016 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.016 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.015 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.015 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.015 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.014 | ||
| MEFV | Mediterranean fever | 0.014 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.014 | Human | |
| IL10 | interleukin 10 | 0.014 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.013 | Human | |
| ZNF746 | zinc finger protein 746 | 0.013 | ||
| IFNG | interferon, gamma | 0.013 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.013 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.012 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.012 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.012 | Human | |
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.011 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.011 | ||
| PGF | placental growth factor | 0.011 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.011 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.011 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.010 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.010 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.010 |